Skip to content

The correlation between brown fat thermogenesis and serum obesity-related biomarkers in adults

The correlation between brown fat thermogenesis and serum obesity-related biomarkers in adults

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600130658
Enrollment
Unknown
Registered
2026-08-23
Start date
2023-10-09
Completion date
Unknown
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight

Interventions

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Before conducting any activities related to the trial, informed consent has been obtained; 2. Age >= 18 years and < 60 years; 3. Male or female; 4. Body mass index between 18.5 and 40 kg/m^2.

Exclusion criteria

Exclusion criteria: Participants were excluded from the study if they had: (1) a history of any of the following conditions before screening: 1) severe hypertension (systolic blood pressure >=180mmHg, and/or diastolic blood pressure >=110mmHg) and 2) cardiovascular disease, defined as: Stroke, decompensated heart failure NYHA class 3 or 4, myocardial infarction, unstable angina or coronary artery bypass grafting or angioplasty 3) history of endocrine disease such as thyroid, pituitary, or adrenal gland 4) clinically significant abnormal gastric emptying, severe chronic gastrointestinal disease, or long-term use of drugs that have a direct effect on gastrointestinal peristalsis 5) history of cancer or cancer 6) history of autoimmune disease 7) history of gastrointestinal, brain surgery, or trauma. (2) Any of the laboratory indicators before screening met the following criteria: 1) any one of FT3,FT4,TSH beyond the reference range 2) liver function injury, ALT or AST>=2.5ULN 3) renal function injury, serum creatinine >=125umol/l in male; Women with serum creatinine > 110umol/l (3) had received antidiabetic drugs, antihypertensive drugs, weight loss drugs, and long-term (more than 7 consecutive days) intravenous, oral, or intra-articular corticosteroid administration within 6 months before screening. (4) pregnant or lactating women, and (5) known or suspected abuse of alcohol, narcotics, or illegal drugs

Design outcomes

Primary

MeasureTime frame
Brown fat thermogenesis;

Secondary

MeasureTime frame
Waistline;Blood pressure;Body temperature;Hipline;Body weight;Blood biochemistry;Pulse;Height;

Countries

China

Contacts

Public ContactSiwen Zhang

The First Hospital of Jilin University

15143080779@163.com+86 431 81875401

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026